Elderia Ahmed, Kiehn Ellen, Djordjevic Ilija, Gerfer Stephen, Eghbalzadeh Kaveh, Gaisendrees Christopher, Deppe Antje-Christin, Kuhn Elmar, Wahlers Thorsten, Weber Carolyn
Department of Cardiothoracic Surgery, Heart Center, University of Cologne, 50937 Köln, Germany.
J Clin Med. 2023 Sep 13;12(18):5948. doi: 10.3390/jcm12185948.
Infective endocarditis (IE) carries a heavy burden of morbidity and mortality in chronic kidney disease (CKD) and hemodialysis (HD) patients. We investigated the risk factors, pathognomonic profile and outcomes of surgically treated IE in CKD and HD patients. We preoperatively identified patients with CKD under hemodialysis (HD group) and compared them with patients without hemodialysis (Non-HD group). Furthermore, we divided the cohort into four groups according to the underlying stage of CKD, with a subsequent outcome analysis. Between 2009 and 2018, 534 Non-HD and 58 HD patients underwent surgery for IE at our institution. The median age was 65.1 [50.6-73.6] and 63.2 [53.4-72.8] years in the Non-HD and HD groups, respectively ( = 0.861). The median EuroSCORE II was 8.0 [5.0-10.0] vs. 9.5 [7.0-12.0] in the Non-HD vs. HD groups ( = 0.004). Patients without CKD had a mortality rate of 5.6% at 30 days and 15.5% at 1 year. Mortality rates proportionally rose with the severity of CKD. Among HD patients, 30-day and 1-year mortality rates were 38.1% and 75.6%, respectively ( < 0.001). IE was significantly more frequent in the HD group ( = 0.006). In conclusion, outcomes after surgery for IE correlated with the severity of the underlying CKD, with HD patients exhibiting the most unfavorable results. Pre-existing CKD and staphylococcus aureus infection were independent risk factors for 1-year mortality.
感染性心内膜炎(IE)在慢性肾脏病(CKD)和血液透析(HD)患者中导致了沉重的发病和死亡负担。我们调查了CKD和HD患者接受手术治疗的IE的危险因素、特征性表现及预后。我们术前确定了接受血液透析的CKD患者(HD组),并将其与未接受血液透析的患者(非HD组)进行比较。此外,我们根据CKD的基础分期将队列分为四组,随后进行预后分析。2009年至2018年期间,我院有534例非HD患者和58例HD患者接受了IE手术。非HD组和HD组的中位年龄分别为65.1[50.6 - 73.6]岁和63.2[53.4 - 72.8]岁(P = 0.861)。非HD组和HD组的欧洲心脏手术风险评估系统(EuroSCORE)II中位数分别为8.0[5.0 - 10.0]和9.5[7.0 - 12.0](P = 0.004)。无CKD的患者30天死亡率为5.6%,1年死亡率为15.5%。死亡率随CKD严重程度成比例上升。在HD患者中,30天和1年死亡率分别为38.1%和75.6%(P < 0.001)。IE在HD组中明显更常见(P = 0.006)。总之,IE手术后的预后与基础CKD的严重程度相关,HD患者的结果最不理想。既往存在的CKD和金黄色葡萄球菌感染是1年死亡率的独立危险因素。